These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36756751)

  • 21. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
    BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
    Liu GL; Yang HJ; Liu B; Liu T
    J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression.
    Yuan H; Gao Y
    Oncol Rep; 2015 Nov; 34(5):2706-14. PubMed ID: 26328886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
    Long J; Liu B; Yao Z; Weng H; Li H; Jiang C; Fang S
    Int J Gen Med; 2022; 15():1891-1899. PubMed ID: 35221718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-181a/b-1 over-expression enhances osteogenesis by modulating PTEN/PI3K/AKT signaling and mitochondrial metabolism.
    Zheng H; Liu J; Tycksen E; Nunley R; McAlinden A
    Bone; 2019 Jun; 123():92-102. PubMed ID: 30898695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells.
    Jiang L; Liu XQ; Ma Q; Yang Q; Gao L; Li HD; Wang JN; Wei B; Wen J; Li J; Wu YG; Meng XM
    FASEB J; 2019 Mar; 33(3):3523-3535. PubMed ID: 30365367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High intensity focused ultrasound inhibits melanoma cell migration and metastasis through attenuating microRNA-21-mediated PTEN suppression.
    Li H; Yuan SM; Yang M; Zha H; Li XR; Sun H; Duan L; Gu Y; Li AF; Weng YG; Luo JY; He TC; Wang Y; Li CY; Li FQ; Wang ZB; Zhou L
    Oncotarget; 2016 Aug; 7(31):50450-50460. PubMed ID: 27391071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA 142-5p promotes tumor growth in oral squamous cell carcinoma via the PI3K/AKT pathway by regulating PTEN.
    Iizumi S; Uchida F; Nagai H; Takaoka S; Fukuzawa S; Kanno NI; Yamagata K; Tabuchi K; Yanagawa T; Bukawa H
    Heliyon; 2021 Oct; 7(10):e08086. PubMed ID: 34693046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
    Wu AY; Hu Y; Cang W; Li D; Wang WJ; Tian Q; Gu LY; Zhang N; Ji F; Qiu LH
    Exp Cell Res; 2019 Sep; 382(2):111468. PubMed ID: 31201812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways.
    Zhang Y; Chen D; Zhang G; Wu X; Zhou L; Lin Y; Ding J; An F; Zhan Q
    Oncol Lett; 2020 Nov; 20(5):160. PubMed ID: 32934728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression.
    Li C; Song L; Zhang Z; Bai XX; Cui MF; Ma LJ
    Oncotarget; 2016 Oct; 7(41):66989-67003. PubMed ID: 27611950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.
    Sheng WZ; Chen YS; Tu CT; He J; Zhang B; Gao WD
    World J Gastroenterol; 2016 Jun; 22(24):5532-9. PubMed ID: 27350731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten/Akt/P-Akt signaling pathway.
    Chen X; Huang Z; Chen R
    Oncol Lett; 2018 Apr; 15(4):4683-4689. PubMed ID: 29541241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-21 activation of Akt
    Lu X; Liu Y; Luo F; Zhang A; Liu X; Lu L; Shi L; Li J; Xue J; Xu H; Fan W; Liu Q
    Toxicol Res (Camb); 2016 Jul; 5(4):1140-1147. PubMed ID: 30090420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomal MiR-500a-3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer.
    Lin H; Zhang L; Zhang C; Liu P
    J Cell Mol Med; 2020 Aug; 24(16):8930-8941. PubMed ID: 32588541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.
    Chai C; Song LJ; Han SY; Li XQ; Li M
    CNS Neurosci Ther; 2018 May; 24(5):369-380. PubMed ID: 29316313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-367 promotes progression of hepatocellular carcinoma through
    Wang Z; Luo Y
    Biosci Rep; 2019 Sep; ():. PubMed ID: 31541003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.